Articles from BIOTECH Patent News (February 1, 2002)

1-39 out of 39 article(s)

Title	Type	Words
Advanced Brain Monitoring Awarded $1.2 Million.		350
Amarillo obtains interferon alpha patent.	Brief Article	318
Amersham and Applied Biosystems settle litigation.		537
Anti-angiogenic ribozyme patent issued to Ribozyme.	Brief Article	461
Baxter obtains United States patent.	Brief Article	97
Beyond Genomics and diaDexus enter cancer diagnostic research agreement.	Brief Article	560
BioDiscovery granted microarray patent.	Brief Article	155
Biosite to engineer around XOMA patent.	Product Announcement	534
BOC Group obtains United States patent.	Brief Article	114
British Biotech and MethylGene sign agreement on phase II antisense drug.		1481
BSD Medical licenses rights to NIH non-invasive deep hyperthermia cancer therapy.	Brief Article	411
Canji obtains United States patent.	Brief Article	79
Catheter used in early, aggressive treatment for sepsis.		494
Ceva Sante Animale obtains United States patent.	Brief Article	111
du Pont obtains United States patent.	Brief Article	182
Duke obtains United States patent.	Brief Article	54
Edema Clearance obtains United States patent.	Brief Article	113
Eli Lilly obtains United States patent.	Brief Article	47
GeneProt licences Oxford's automated proteomics patents.	Brief Article	624
Genesis and Immunex sign collaboration agreement.	Brief Article	336
Genset obtains United States patent.	Brief Article	127
GenVec signs contract for preventative AIDS vaccine.	Brief Article	566
Hydron files patent for acne treatment delivery system.	Brief Article	314
Imaging Diagnostic obtains breast imaging patent.	Brief Article	337
Infigen clones industry's first pigs from adult cells.	Brief Article	502
Ludwig Institute obtains United States patent.	Brief Article	57
Massachusetts Institute of Technology obtains United States patent.	Brief Article	127
MorphoSys and XOMA cross-license antibody technologies.	Brief Article	729
NeoTherapeutics issued patent for stimulating growth of neurons.	Brief Article	309
Oncolytics patents neoplasia treatment.	Brief Article	194
Pharmacopeia and Organon to collaborate on identification.	Brief Article	615
ProteoTech receives two Alzheimer's disease patents.	Brief Article	329
Ribozyme obtains United States patent.	Brief Article	62
Syngenta obtains United States patent.	Brief Article	153
Takara Shuzo obtains United States patent.	Brief Article	117
Targeted Genetics obtains gene expression patent.	Brief Article	460
The Babraham Institute obtains United States patent.	Brief Article	47
The Carnegie Institution obtains United States patent.	Brief Article	70
The UAB Research Foundation obtains United States patent.	Brief Article	245